Skip to main content
Premium Trial:

Request an Annual Quote

GE Healthcare, GlaxoSmithKline Ink Data-Integration Deal

NEW YORK, Nov. 1 (GenomeWeb News) - GE Healthcare will help GlaxoSmithKline develop an informatics system to integrate data from internal and external drug-discovery R&D sources, the companies said today.

 

Under the deal, GlaxoSmithKline will be able to use GE Healthcare's GeneticXchange's DiscoveryHub data- and information-integration software in its genetics, discovery, and pre-clinical-development R&D groups.

 

Additionally, the deal calls for GE Healthcare and GlaxoSmithKline to design, develop, and support next-generation DiscoveryHub technology.

Financial terms of the deal were not disclosed.

 

For additional details about the deal, see this week's issue of BioInform, GenomeWeb News' sister publication.

The Scan

Germline-Targeting HIV Vaccine Shows Promise in Phase I Trial

A National Institutes of Health-led team reports in Science that a broadly neutralizing antibody HIV vaccine induced bnAb precursors in 97 percent of those given the vaccine.

Study Uncovers Genetic Mutation in Childhood Glaucoma

A study in the Journal of Clinical Investigation ties a heterozygous missense variant in thrombospondin 1 to childhood glaucoma.

Gene Co-Expression Database for Humans, Model Organisms Gets Update

GeneFriends has been updated to include gene and transcript co-expression networks based on RNA-seq data from 46,475 human and 34,322 mouse samples, a new paper in Nucleic Acids Research says.

New Study Investigates Genomics of Fanconi Anemia Repair Pathway in Cancer

A Rockefeller University team reports in Nature that FA repair deficiency leads to structural variants that can contribute to genomic instability.